Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 7/20 | 0.56 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 6/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.52 |
| ▸ | HTT | P42858 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | ADORA1 | P30542 | 6/20 | 0.52 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.52 |
| ▸ | RORC | P51449 | 1/20 | 0.47 |
| ▸ | RORB | Q92753 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10242397 | 0.76 | ADORA3 (0.61) | ADORA3ADORA2BNPSR1SMN1; SMN2HTT | |
| SCHEMBL165773 | 0.76 | ADORA3 (0.61) | ADORA3ADORA2BNPSR1SMN1; SMN2HTT | |
| SCHEMBL4425292 | 0.74 | KDM1A (0.47) | NPSR1SMN1; SMN2ALDH1A1LMNAALOX5 | |
| SCHEMBL3456228 | 0.74 | ADORA2B (0.62) | ADORA3ADORA2BNPSR1SMN1; SMN2HTT | |
| SCHEMBL5330562 | 0.71 | CDC7 (0.51) | ADORA3ADORA2BNPSR1SMN1; SMN2HTT | |
| SCHEMBL178218 | 0.70 | ADORA3 (0.60) | ADORA3ADORA2BNPSR1SMN1; SMN2HTT | |
| SCHEMBL257616 | 0.70 | ADORA3 (0.64) | ADORA3ADORA2BNPSR1SMN1; SMN2ALDH1A1 | |
| SCHEMBL27653975 | 0.68 | ADORA3 (0.51) | ADORA3ADORA2BNPSR1SMN1; SMN2HTT | |
| SCHEMBL1249616 | 0.68 | ADORA3 (0.51) | ADORA3ADORA2BNPSR1SMN1; SMN2HTT | |
| SCHEMBL10092883 | 0.68 | RORB (0.67) | ADORA3ADORA2BALDH1A1ADORA1ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1829714-B | Pna monomer and precursor | PANAGENE INC | 2012-05-30 | — | — | CN | disclosed |
| EP-1651642-B1 | PNA MONOMER AND PRECURSOR | PANAGENE INC (KR) | 2009-11-04 | — | — | EP | disclosed |
| US-7211668-B2 | PNA monomer and precursor | PANAGENE, INC. (KR) | 2007-05-01 | — | — | US | disclosed |
| EP-1651642-A4 | PNA MONOMER AND PRECURSOR | PANAGENE INC (KR) | 2006-11-29 | — | — | EP | disclosed |
| CN-1829714-A | PNA monomer and precursor | PANAGENE INC (KR) | 2006-09-06 | — | — | CN | disclosed |
| EP-1651642-A1 | PNA MONOMER AND PRECURSOR | Panagene Inc. (KR) | 2006-05-03 | — | — | EP | disclosed |
| US-20050026930-A1 | PNA monomer and precursor | PANAGENE, INC. (KR) | 2005-02-03 | — | — | US | disclosed |
| WO-2005009998-A1 | PNA MONOMER AND PRECURSOR | PANAGENE INC. (US) | 2005-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050026930-A1 | PNA monomer and precursor | RNGTT, POLL, NSUN3 | ADORA3 127/4885ADORA2B 173/4885NPSR1 156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.